You are here

Antimicrobial Surveillance

Body: 

What is antimicrobial surveillance?

Antimicrobial surveillance refers to efforts to monitor the rate and patterns of resistance to anti-infectives. It can be conducted on a global, regional and local country basis.

Why is surveillance crucial?

Antimicrobial resistance (AMR) occurs when pathogens change and find ways to resist the effects of anti-infectives. AMR, particularly in Gram-negative bacteria, is widely recognized as one of the biggest threats to global public health today; causing 700,000 deaths annually.1

体育投注正规网址Surveillance is a vital tool for clinicians and public health officials to slow the rise of AMR:

  • Providing early warning of emerging threats and helping decision-makers intervene before they escalate.
  • Guiding public health policy and infection prevention and control plans.
  • Allowing physicians to make better clinical decisions to improve patient outcomes.

About the ATLAS program ATLAS_Logo.png

Pfizer sponsors one of the largest AMR surveillance programs in the world – The Antimicrobial Testing Leadership and Surveillance (ATLAS) database.2 ATLAS is a fully searchable, interactive, user-friendly website and mobile application that provides free, rapid access – to anyone – to extensive data* on emerging bacterial resistance patterns and sensitivity to antibiotics. Pfizer’s ATLAS program was highlighted by the 2020 Access to Medicines Benchmark Report on AMR for the “pioneering move” of being the only company to share “not only its results, but also its raw data in the , an open access platform”.3

ATLAS helps fight the threat of AMR

体育投注正规网址ATLAS provides decision makers and patients with near real-time access to resistance trends, enabling them to adapt stewardship and infection control and prevention programs accordingly.

Expanding the scope of ATLAS

体育投注正规网址We are continuously exploring ways to evolve our resources to meet the changing needs of the infectious diseases community and halt the spread of resistant pathogens.

This includes evolving ATLAS from an industry-recognized antibacterial surveillance platform to a broader antimicrobial surveillance program, with the inclusion of antifungal data via the integration of SENTRY surveillance data. SENTRY adds data from over 15,500 fungal isolates, collected from 40 countries, making Pfizer the only company to provide public access to both antifungal and antibiotic resistance data through a single platform.6

*ATLAS represents the integration of three surveillance programs: TEST (Tigecycline evaluation Surveillance Trial), AWARE (Assessing Worldwide Antimicrobial Resistance Evaluation) and INFORM (International Network for Optimal Resistance Monitoring).

Body: 

References

  1. Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. May 2016. Available at: Last accessed March 2020.
  2. AMR Industry Alliance. Pfizer – Antimicrobial Testing Leadership and Surveillance (ATLAS). Available at: Last accessed March 2020.
  3. Access to Medicine Foundation. Antimicrobial resistance benchmark 2020. Available at: . Last accessed March 2020.
  4. AMR Industry Alliance. Case study: Pfizer - Antimicrobial Testing Leadership and Surveillance (ATLAS) Available at: Last accessed March 2020.
  5. Pfizer. Antimicrobial Testing Leadership and Surveillance. Available at: Last accessed March 2020.
  6. Global Health Progress. Pfizer Global Antimicrobial Surveillance Programs. Available at: Last accessed March 2020.